Literature DB >> 25219323

Glycogen metabolism in cancer.

Christos E Zois1, Elena Favaro2, Adrian L Harris3.   

Abstract

Since its identification more than 150 years ago, there has been an extensive characterisation of glycogen metabolism and its regulatory pathways in the two main glycogen storage organs of the body, i.e. liver and muscle. In recent years, glycogen metabolism has also been demonstrated to be upregulated in many tumour types, suggesting it is an important aspect of cancer cell pathophysiology. Here, we provide an overview of glycogen metabolism and its regulation, with a focus on its role in metabolic reprogramming of cancer cells. The various methods to detect glycogen in tumours in vivo are also reviewed. Finally, we discuss the targeting of glycogen metabolism as a strategy for cancer treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Glycogen metabolism; Hypoxia; Pentose shunt

Mesh:

Substances:

Year:  2014        PMID: 25219323     DOI: 10.1016/j.bcp.2014.09.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

1.  Homeostasis and the glycogen shunt explains aerobic ethanol production in yeast.

Authors:  Robert G Shulman; Douglas L Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 2.  T cell metabolic reprogramming and plasticity.

Authors:  Maria Slack; Tingting Wang; Ruoning Wang
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

Review 3.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

4.  Discrimination of malignant from benign thyroid lesions through neural networks using FTIR signals obtained from tissues.

Authors:  Abegail Santillan; Rock Christian Tomas; Ruth Bangaoil; Rolando Lopez; Maria Honolina Gomez; Allan Fellizar; Antonio Lim; Lorenzo Abanilla; Maria Cristina Ramos; Leonardo Guevarra; Pia Marie Albano
Journal:  Anal Bioanal Chem       Date:  2021-02-10       Impact factor: 4.142

Review 5.  Glucose Metabolism in Cancer.

Authors:  Sminu Bose; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  Oxygen availability and metabolic reprogramming in cancer.

Authors:  Hong Xie; M Celeste Simon
Journal:  J Biol Chem       Date:  2017-08-24       Impact factor: 5.157

7.  Phosphorylase kinase β affects colorectal cancer cell growth and represents a novel prognostic biomarker.

Authors:  Guanghui Wang; Wenbin Shen; Chen-Ying Liu; Yun Liu; Tingyu Wu; Ximao Cui; Tong Yu; Yilian Zhu; Jinglue Song; Peng Du; Long Cui
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-08       Impact factor: 4.553

8.  4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase.

Authors:  Éva Bokor; Sándor Kun; Tibor Docsa; Pál Gergely; László Somsák
Journal:  ACS Med Chem Lett       Date:  2015-10-19       Impact factor: 4.345

9.  Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways.

Authors:  Rituraj Pal; Yan Xiong; Marco Sardiello
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-06       Impact factor: 11.205

10.  Chemically Modified Dendritic Starch: A Novel Nanomaterial for siRNA Delivery.

Authors:  Sarah A Engelberth; Nadine Hempel; Magnus Bergkvist
Journal:  Bioconjug Chem       Date:  2015-08-11       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.